Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Restructuring Costs (2022 - 2023)

Bioregenx (BRGX) has 2 years of Restructuring Costs data on record, last reported at $6193.0 in Q4 2023.

  • For Q4 2023, Restructuring Costs fell 8.43% year-over-year to $6193.0; the TTM value through Dec 2023 reached $18254.0, down 33.97%, while the annual FY2023 figure was $18254.0, 33.97% down from the prior year.
  • Restructuring Costs reached $6193.0 in Q4 2023 per BRGX's latest filing, up from $1003.0 in the prior quarter.
  • Across five years, Restructuring Costs topped out at $9168.0 in Q1 2023 and bottomed at $1003.0 in Q3 2023.